Coexistence of chronic obstructive pulmonary disease in patients with advanced non-small cell lung cancer and impact on survival Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery Source: Virtual Congress 2020 – Localised non-small cell lung cancer Year: 2020
The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005
Coexistence of COPD in lung cancer patients Source: Eur Respir J 2001; 18: Suppl. 33, 66s Year: 2001
Predictive factors for the incidence of lung cancer (LC) complicated in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019
Chronic obstructive pulmonary disease and interstitial lung disease could predict poor long-term survivals after pulmonary resection for lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 38s Year: 2002
COPD in patients with lung cancer and smoking Source: Eur Respir J 2005; 26: Suppl. 49, 519s Year: 2005
Clinical characteristics of postoperative pulmonary infection in lung cancer patients with obstructive pulmonary disease: the trend of microorganisms in bronchial colonization Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006
Bilateral lung cancer with COPD or metastatic disease Source: International Congress 2016 – CC4 Major challenges in thoracic surgical oncology Year: 2016
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history Source: Eur Respir J 2009; 33: 380-386 Year: 2009
Prognosis of non-small-cell lung cancer in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018
Pecularities of lung cancer in patients with COPD Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011
COPD as an independent risk factor for lung cancer in patients with bronchial squamous dysplasia Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011
Risk factors for lung cancer in COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017
A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 361s Year: 2003
Incidence of lung cancer among COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 494s Year: 2005
The link between inflammation and lung cancer: lessons from chronic obstructive pulmonary disease Source: International Congress 2018 – Scientific Year in Review Year: 2018
A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012